Browse studies
Find your next paid study
16 recruiting studies matching your filters
Phase 2
Use of NAD Oxidase Modulation Agent QRX3 for Prevention and Treatment of Progressive Chronic Kidney Disease
Chronic kidney disease CKD is estimated to affect nearly over 800 million people globally today (with roughly 125,000 people ending up annually on dialysis in …
Chronic Kidney DiseasesAcute Kidney InjuryKidney Failure
Estimated
~$10 – $7,500
Ebima Clifford OkundayeNCT06866236
Phase 1
Addition of Venetoclax to Combined Reduced Intensity Hematopoietic Stem Cell and Kidney Transplantation for Patients With Chronic Kidney Disease and Hematologic Malignancy
The primary objective is to assess the safety of the addition of venetoclax to reduced intensity conditioning for HLA-matched and haploidentical combined HSC a…
Kidney Failure ChronicStem Cell TransplantStem Cell Transplant Complications+2 more
Estimated
~$10 – $6,250
Massachusetts General HospitalNCT07358195
International (Pediatric) Peritoneal Biobank
Within few years the peritoneal membrane of adult peritoneal dialysis (PD) patients undergoes substantial morphological transformation, including progressive f…
Kidney Failure, ChronicPeritoneal Dialysis ComplicationTransplantation+1 more
Estimated
~$10 – $750
Heidelberg UniversityNCT01893710
Phase 3
Effectiveness and Safety of Sotagliflozin in Slowing Kidney Function Decline in Persons With Type 1 Diabetes and Moderate to Severe Diabetic Kidney Disease
Powerful new drugs that can prevent or delay end stage kidney disease (ESKD) - so called sodium-glucose cotransporter-2 inhibitors (SGLT2i) - are now available…
Diabetic NephropathiesKidney Failure, ChronicDiabetes Mellitus Type 1+1 more
Estimated
~$10 – $7,500
Alessandro DoriaNCT06217302